The Scottish Medicines Consortium (SMC) are assessing whether or not to recommend pertuzumab (Perjeta) given after surgery to be available on the NHS in Scotland. Pertuzumab is a treatment for HER2 positive breast cancer. Women who live in England, Wales and Northern Ireland can get it on the NHS, but it's not currently available in Scotland.
We are gathering evidence to tell the SMC what access to pertuzumab would mean and want to hear from: women who have been or are being treated with pertuzumab after surgery in England, Wales and Northern Ireland, or women in Scotland who have HER2 positive breast cancer.
Please help us by telling us about your experience of this here: https://breastcancernow.org/about-us/tell-us-your-story
If you have any questions about our work in this area, please email firstname.lastname@example.org.